How to check GLP-1 coverage with Aetna
Verified coverage details by drug are below, followed by the process for checking your own plan.
Sources last checked September 21, 2026
Aetna is a CVS Health company. Pharmacy benefits are often administered with CVS Caremark, but the number on your ID card is the one that can see your specific plan.
What we've verified about Aetna GLP-1 coverage
Ozempic
Ozempic is listed on the CVS Caremark Value Formulary dated 07/01/2026 with step therapy and quantity limit flags. Caremark prior authorization policy 5694-D approves Ozempic for type 2 diabetes when the patient has a documented A1C of 6.5 percent or higher or meets one of the other listed glucose criteria. It does not require a metformin trial, and approval runs 36 months. Weight loss is not listed as an indication in the policy. Aetna also publishes its own policies for some plans, so confirm which one applies to your plan.
Source: CVS Caremark Value Formulary (07/01/2026); Caremark prior authorization policy 5694-D, 07/01/2026 (formulary); policy 5694-D (no revision date stated)
Mounjaro
Mounjaro carries step therapy and quantity limit flags on the CVS Caremark Value Formulary dated 07/01/2026. Caremark prior authorization policy 5694-D approves Mounjaro for type 2 diabetes when the patient has a documented A1C of 6.5 percent or higher or meets one of the other listed glucose criteria, with no metformin trial required and a 36-month approval. Aetna also publishes its own Mounjaro policy (5468-C, 05-2024 edition), which asks for an inadequate response to, intolerance of or contraindication to metformin and limits fills to 4 pens per 21 days, and its page does not clearly say which plans it applies to. Confirm which policy applies to your plan.
Source: Caremark prior authorization policy 5694-D; Aetna policy 5468-C (Mounjaro), Policy 5694-D (no revision date stated); Aetna 5468-C UDR 05-2024
Wegovy
The CVS Caremark Value Formulary (07/01/2026) lists Wegovy injection and tablets with no step therapy or quantity limit flags. Caremark policy 4774-C requires prior authorization, at least 6 months in a comprehensive weight management program, and BMI of 30 or higher (or 27 or higher with a comorbidity). Plan sponsors can still exclude weight-loss drugs entirely, so this is a default, not a guarantee. Aetna also publishes its own weight-loss policies for some plans with different criteria, so confirm which policy applies to your plan.
Source: Caremark PA policy 4774-C (Wegovy) and CVS Caremark Value Formulary, July 2026
Zepbound
Aetna's Standard Plan exclusion list (July 2026) excludes Zepbound and points to Wegovy, but Aetna's formulary updates effective October 1, 2026 list Zepbound as added in the Antiobesity class. CVS Caremark announced on May 28, 2026 that it will add Zepbound back to its commercial formularies as an additional preferred option on October 1, 2026, and plan sponsors keep discretion to customize. Caremark policy 6947-C requires at least 6 months in a comprehensive weight management program and a BMI of 30 or higher (or 27 or higher with a comorbidity), with an 8-month first approval.
Source: CVS Health: CVS Caremark GLP-1 weight management expanded coverage options (press release), 2026-05-28
Formularies differ by employer, state, Medicare vs. commercial, and PBM carve-out. The only reliable answer is the number on your ID card plus a written prior-auth decision.
Full 5-step checklist →Who to call
Aetna’s own member-services page says this is the number that can see your plan. The corporate line cannot look up your account.
Official contact directory: Aetna’s official Contact Aetna page. Member portal: https://www.aetna.com.
How prior authorization usually works here
- Call the Member Services number on your ID card — not a general Aetna marketing line — and ask them to look up your specific formulary.
- Ask whether the drug is covered for your diagnosis (type 2 diabetes vs. obesity/weight management vs. another FDA indication). Aetna does not publish one national yes/no for GLP-1s that applies to every employer, Medicare, or individual plan.
- If they say it is on formulary, ask the tier, your estimated copay/coinsurance, whether prior authorization is required, and whether step therapy or quantity limits apply.
- Ask your prescriber’s office to submit prior authorization electronically when required. Aetna’s provider materials point offices to Availity, CoverMyMeds, or Aetna Pharmacy Management rather than a member-completed form.
- If the request is denied, ask Member Services for the denial reason in writing and how to file an appeal or formulary exception. Then ask the clinic’s prior-auth staff to resubmit with the missing documentation.
What to ask on the call
- Is [drug name] on my formulary for [diagnosis]?
- What tier is it, and what would I pay for a 28- or 30-day supply at a preferred pharmacy?
- Is prior authorization required? If yes, what clinical criteria does Aetna/CVS Caremark use for my plan (BMI, A1C, prior medication trials, cardiovascular diagnosis, etc.)?
- Should my clinician submit through CoverMyMeds, Availity, or another portal?
- If this is denied, what is the appeal deadline and what documentation do you need?
By drug
- Does Aetna cover Ozempic?
- Does Aetna cover Mounjaro?
- Does Aetna cover Wegovy?
- Does Aetna cover Zepbound?
All insurers with published drug pages
Other major insurers
Manufacturer savings programs and cash-pay telehealth are the usual next step — they still depend on your situation, not on this page.
See Cash-Pay Options →Phone numbers and portal names are taken from Aetna's public contact pages linked above. They change, and they are not a substitute for the number printed on your ID card. This page does not make coverage claims for any GLP-1 medication.